Adma Biologics (ADMA) Tops Q1 EPS by 1c

Adma Biologics (NASDAQ: ADMA) reported Q1 EPS of ($0.37), $0.01 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.5 million.

For earnings history and earnings-related data on Adma Biologics (ADMA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates